Unlock instant, AI-driven research and patent intelligence for your innovation.

Synthesis method of dasatinib intermediate

A technology of dasatinib and a synthesis method, applied in the field of drug synthesis, can solve the problems of difficult condensation reaction, large environmental pressure, many by-products, etc., and achieve the effects of easy industrial production, avoiding waste of raw materials, and simple raw materials

Inactive Publication Date: 2017-03-29
SHANDONG BOYUAN PHARM CO LTD
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In the above synthetic route, the condensation reaction between 4,6-dichloro-2-methylpyrimidine and 1-(2-hydroxyethyl)piperazine is not easy to carry out, and 1-(2-hydroxyl Ethyl) piperazine, this must cause a large amount of waste of raw materials
Simultaneously at present the main synthetic method of 1-(2-hydroxyethyl) piperazine is the disclosed method of CN103298806 A, first reacts by 1-BOC-piperazine and 2-bromoethanol, then takes off BOC protection to obtain 1-(2 -Hydroxyethyl) piperazine, the by-product of this reaction (as the BOC that sloughs off) is more, has brought bigger environmental protection pressure to the industrialized production of product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of dasatinib intermediate
  • Synthesis method of dasatinib intermediate
  • Synthesis method of dasatinib intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] (1) Add 500ml of chloroform, 60g of 2-methyl-4-amino-6-chloropyrimidine, 71.2g of bis(2-chloroethyl)amine, and 87g of potassium carbonate to a 1000ml reaction flask, start stirring, and heat to reflux for 5 After being down to room temperature, the insoluble solids were removed by filtration, and the filtrate was washed with 200ml of saturated sodium chloride solution;

[0025] (2) Then add 40.4g of 2-chloroethanol and 63g of triethylamine to the filtrate, heat and reflux for 4 hours, after the reaction is completed, drop to room temperature, wash with 100ml of hydrochloric acid of 1mol / L, then wash once with 100ml of saturated sodium bicarbonate solution , washed once with 100ml of purified water, then concentrated the organic layer under reduced pressure, added 440g of n-hexane and 110g of ethyl acetate, heated to 50°C, stirred for 1 hour; cooled to 5°C and continued to stir for 30 minutes, suction filtered and dried to obtain 91.5g Off-white solid with a yield of 85....

Embodiment 2

[0027] (1) Add 500ml of chloroform, 60g of 2-methyl-4-amino-6-chloropyrimidine, 71.0g of bis(2-chloroethyl)amine, and 85g of potassium carbonate to a 1000ml reaction bottle, start stirring, and heat to reflux for reaction 6 After being down to room temperature, the insoluble solids were removed by filtration, and the filtrate was washed with 200ml of saturated sodium chloride solution;

[0028] (2) Then add 40.0g of 2-chloroethanol and 60g of triethylamine to the filtrate, heat and reflux for 5 hours, after the reaction is completed, drop to room temperature, wash with 100ml of hydrochloric acid of 1mol / L, then wash once with 100ml of saturated sodium bicarbonate solution , washed once with 100ml of purified water, then concentrated the organic layer under reduced pressure, added 440g of n-hexane and 110g of ethyl acetate, heated to 50°C, stirred for 1 hour; cooled to 5°C and continued to stir for 30 minutes, suction filtered and dried to obtain 91.2g Off-white solid, yield 85...

Embodiment 3

[0030] (1) Add 500ml of chloroform, 60g of 2-methyl-4-amino-6-chloropyrimidine, 71.8g of bis(2-chloroethyl)amine, and 90g of potassium carbonate to a 1000ml reaction bottle, start stirring, and heat to reflux for 4.5 After being down to room temperature, the insoluble solids were removed by filtration, and the filtrate was washed with 200ml of saturated sodium chloride solution;

[0031] (2) Then add 41.0 g of 2-chloroethanol and 65 g of triethylamine to the filtrate, heat and reflux for 3.5 hours, after the reaction is completed, drop to room temperature, wash with 100 ml of hydrochloric acid of 1 mol / L, then wash once with 100 ml of saturated sodium bicarbonate solution , washed once with 100ml of purified water, then concentrated the organic layer under reduced pressure, added 440g of n-hexane and 110g of ethyl acetate, heated to 50°C, stirred for 1 hour; cooled to 5°C and continued to stir for 30 minutes, suction filtered and dried to obtain 91.8g Off-white solid, yield 85...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a synthesis method of a dasatinib intermediate. The method comprises the following steps: taking 2-methyl-4-amino-6-chloropyridine and bi(2-chloroethyl)amine to react to generate 2-methyl-6-chloro-pyridine-4-yl piperazine; and taking the 2-methyl-6-chloro-pyridine-4-yl piperazine and 2-ethylene chlorohydrin to react to generate 2-[4-(2-methyl-6-chloro-pyridine-4-yl)piperazine-1-yl]ethanol. The method disclosed by the invention has the advantages of simplicity and easiness of obtaining raw materials, simplicity in operation, high product yield, high purity and easiness of industrial production.

Description

technical field [0001] The invention relates to a method for synthesizing a dasatinib intermediate, belonging to the technical field of drug synthesis. Background technique [0002] Dasatinib is an oral tyrosine kinase inhibitor developed by Bristol-Myers Squibb. It is indicated for adults with chronic myelogenous leukemia who are resistant or intolerant to imatinib mesylate. patient. At the same time, the FDA also approved dasatinib through normal procedures for the treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who are resistant or intolerant to other therapies. Dasatinib achieved good sales performance in the year when the product came out. [0003] 2-[4-(2-Methyl-6-chloro-pyrimidin-4-yl)piperazin-1-yl]ethanol (CAS: 127116-19-2) is an important intermediate for the synthesis of Dasatinib body. In the synthetic method disclosed in Chinese patent 200580011916.6, 4,6-dichloro-2-methylpyrimidine (compound 7A) and 1-(2-hydrox...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D239/42
CPCC07D239/42
Inventor 赵孝杰张敏刘远慧
Owner SHANDONG BOYUAN PHARM CO LTD